Navigation Links
Alzheimer's drug market to hit $5.5 billion by 2009, study says

Toronto-based Millennium Research Group predicts the Alzheimer's disease drug market in the United States, Europe and Japan will grow by 15 percent annually for the next five years.

Pharmaceutical manufacturers profiled in Millennium's study, entitled "Global Markets for Alzheimer's Disease Medications 2005," include Pfizer, Shire Pharmaceuticals and Novar......

Full article >>> Mithridion is hoping to be one of those companies in five to seven years, according to Johnson.

"There are a number of efforts to identify new approaches that actually treat the pathological process," Johnson noted. "That's in essence what we' re doing.

"We're right at the peak of the wave with this," he said. "It seems like the right time and the right place. We hopefully have a......

Full article >>>
'"/>

Source:wistechnology.com By Lincoln Brunner 05/16/05


Related biology technology :

1. Alzheimers drug developer lands $1.2M in venture funding
2. Biotech firm has strokes, Alzheimers in its sights
3. Mithridion wins grants for Alzheimers research
4. Alzheimers drug firm and more winners named in Wisconsin business-plan contest
5. Marshfield study mixes DNA into electronic medical record to screen for Alzheimers
6. UW Alzheimers researchers found company; privacy law; Science Expeditions
7. Madison-based Mithridion seeks to capitalize on Alzheimers breakthrough
8. Discovery may halt progression of Alzheimers
9. Reforming FDA: Focus on safety, let market judge efficacy
10. Internet-enabled niche markets take center stage
11. GE Healthcare leads compact ultrasound market
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/5/2016)... 2016 According to the ... Products (Consumable, Instruments, Automated Cell Expansion System), Cells ... Cell Research, Cancer, and Cell-Based Research), End-users (Biopharmaceutical ... Global Revenue, Trends, Growth, Share, Size and Forecast ... global cell expansion market is expected to reach ...
(Date:12/5/2016)... WOODCLIFF LAKE, N.J. , Dec. 5, 2016 ... its Phase 3 open-label two-year study of rufinamide, ... of the American Epilepsy Society (AES) held from ... . Analysis of final two-year safety, tolerability and ... therapy with rufinamide experienced similar safety and tolerability ...
(Date:12/4/2016)... (PRWEB) , ... December 03, 2016 , ... ... ground-breaking microbiome studies. A microbiome impact grant award has been made to Dr. ... of heavy smoking and drinking on the oral microbiome. Grant proposals have been ...
(Date:12/2/2016)... 2016 More than $4.3 million was raised last ... DHMD ). The gala was held at the American Museum ... and honored Alan Alda and ... and medicine and the public understanding of science. Since the ... event has raised $40 million for the Laboratory,s research and ...
Breaking Biology Technology:
(Date:11/15/2016)... , Nov. 15, 2016  Synthetic Biologics, Inc. ... therapeutics focused on the gut microbiome, today announced ... 25,000,000 shares of its common stock and warrants ... at a price to the public of $1.00 ... Synthetic Biologics from the offering, excluding the proceeds, ...
(Date:6/22/2016)... , June 22, 2016  The American College of Medical ... Show Executive Magazine as one of the fastest-growing trade ... 25-27 at the Bellagio in Las Vegas ... highest percentage of growth in each of the following categories: ... companies and number of attendees. The 2015 ACMG Annual Meeting ...
(Date:6/16/2016)... FRANCISCO , June 16, 2016 ... size is expected to reach USD 1.83 ... by Grand View Research, Inc. Technological proliferation and ... banking applications are expected to drive the market ... ) , The development of advanced ...
Breaking Biology News(10 mins):